Article Text

Download PDFPDF

OC-011 A novel population of immunosuppressive cd8 t cells is expanded in patients with decompensated liver disease
  1. F Lebossé1,2,
  2. A Singanayagam1,2,
  3. R Nathwani1,
  4. O Pop1,2,
  5. N Kumar1,2,
  6. S Mukherjee1,2,
  7. TZ Hou3,
  8. A Quaglia2,
  9. F Zoulim4,
  10. J Wendon2,
  11. M Thursz1,
  12. A Dhar1,
  13. W Khamri1,
  14. C Antoniades1,2,
  15. C Gudd5
  1. 1Department of Surgery and Cancer, Imperial College
  2. 2Institute of Liver Studies, King’s College
  3. 3Institute of Immunity and transplantation, University College London, London, UK
  4. 4INSERM U1052, Cancerology Research Centre of Lyon, Lyon, France
  5. 5Imperial College, London, UK


Introduction Cirrhosis associated immune dysfunction is central to immuneparesis, infection susceptibility and adverse outcome in patients with chronic liver disease (CLD). Whilst defects in innate immune responses are recognised, the role of adaptive immunity in CLD remains unexplored. Regulatory HLADR+ CD8+ T cells are recently shown to possess immunosuppressive properties. Our aims were to determine whether negative regulation of CD8+ T cell responses contribute to impaired antimicrobial responses in CLD.

Method Circulating CD8 subsets from 33 CLD patients (with chronic cirrhosis, acute decompensation (AD) or acute on chronic liver failure (ACLF)) and 14 healthy controls (HC) were determined using flow cytometry and a panel of phenotypic markers to identify naïve, memory (CD45RO, CD45RA, CCR7, CD62L) subsets as well as expression of activation (CD27, CD28), inhibition (CTLA4, PD1) and suppressive (HLADR, CD25, FOXP3) markers. Immunohistochemistry was performed on explant liver tissue (n=8). Functional analyses of CD8+ T cells were performed using anti-CD3 in the presence of allogeneic dendritic cells or CD3/CD28 beads. Suppressive assay were performed using HLA-DR- or + CD8+ T cells in co-culture with autologous CD3/CD28 stimulated PBMCs.

Results Compared to HC, the proportion of circulating and intrahepatic immunosuppressive HLADR+CD8+ T cells were higher in CLD (mean of 20vs37%;p=0.0002). Immunophenotypic analyses of HLADR+CD8+ T cells identify that these cells are characterised by increased CTLA4 expression compared to HLADR-CD8+ (9.2 vs 0.1%;p<0.0001). HLADR+CD8+ T cells have a mature phenotype (CD45RO+) with lower expression of lymph node homing receptor CCR7. Compared to chronic CLD patients, CTLA4+HLADR+CD8+ T cells are higher in AD patients and lower for ACLF patients (respectively 6.2, 14% and 0.6%, p=0.02). Compared to HLADR-CD8+ T cells, HLADR+ cells exhibit significantly attenuated IL-2 secretion (172 vs 26 pg/mL;p=0.01) in response to in vitro stimulation but a trend to a higher proliferation (76 vs 84%; p=0.053). Finally, in vitro assays show that, contrary to HLADR-CD8+ T cells, HLA-DR+CD8+ T cells could inhibit CD8+ T cells proliferation at different ratio.

Conclusion Our novel data has identified expansion of a regulatory HLADR-expressing CD8 population in CLD patients. These cells are characterised by an elevated CTLA4 expression that is increased in AD patients, suppression of proliferation and may contribute to infection susceptibility in CLD.

Disclosure of Interest None Declared

  • Cirrhosis complication
  • Immunology

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.